Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging.

Area of Science:

• Biomedical optics
• Medical imaging
• Radiochemistry

Background:

• Cerenkov luminescence (CL) is light emitted by charged particles exceeding light speed in a medium.
• CL was discovered in 1934 but gained biomedical relevance in 2009 due to sensitive optical sensors.
• Recent advances enable CL applications in both biomedical imaging and therapy.

Purpose of the Study:

• To review fundamental breakthroughs and recent advances in Cerenkov Luminescence Imaging (CLI).
• To cover developments in reagents and instrumentation for CLI.
• To discuss the therapeutic applications of CL.

Main Methods:

• Utilizing Cerenkov Luminescence Imaging (CLI) with clinically relevant radionuclides.
• Employing advanced optical imaging instrumentation for CL detection.
• Combining CL with positron emission tomography (PET) for multimodal imaging.

Main Results:

• CLI offers advantages over traditional nuclear imaging in cost, resolution, and speed.
• CLI enables multimodal detection using both optical (CL) and PET imaging.
• CL combined with targeted agents shows promise for cancer diagnosis and therapy.

Conclusions:

• CLI is a rapidly expanding field with significant potential in preclinical and clinical research.
• Advances in reagents and instrumentation are enhancing CLI capabilities.
• CL holds promise for novel diagnostic and therapeutic strategies, particularly in oncology.